By Kathryn Brenzel ( August 27, 2013, 12:48 PM EDT) -- Akorn Inc. said on Tuesday that it will buy Long Island, N.Y.-based Hi-Tech Pharmacal Co. Inc. for $640 million, a move that the niche pharmaceutical company hopes will bolster its hold on the generic eye medication market and broaden its offerings with hard-to-make over-the-counter and prescription drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.